
The largest fibromyalgia genetics study to date has successfully pinpointed 26 distinct genetic risk factors linked to the debilitating pain disorder. Published in leading biomedical journals, the research remarkably discovered that one of the primary risk variations resides directly within the Huntington’s disease gene. This monumental breakthrough changes how the medical community views fibromyalgia, shifting the paradigm from a purely subjective condition to a clearly defined neurological and genetic disorder, paving the way for targeted chronic pain management therapies.